Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-001246
Filing Date
2021-02-12
Accepted
2021-02-12 08:13:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 CUE BIOPHARMA, INC. p21-0338sc13ga.htm SC 13G/A 56652
  Complete submission text file 0000902664-21-001246.txt   58312
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Subject) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90232 | Film No.: 21622931
SIC: 2834 Pharmaceutical Preparations